Elena Rivas supports initiatives to deliver cancer treatment innovations to patients
Key Points
- 1. Elena Rivas leads the financing of cancer treatment-focused startups with her over 25 years of experience.
- 2. It is emphasized that technologies like artificial intelligence and precision medicine have radically changed cancer diagnosis and treatment.
- 3. The goal is to attract private equity to the biotechnology field and turn scientific discoveries into companies.
- 4. Rivas, a board member of ASEBIO, has the ultimate goal of delivering biomedical innovations to patients.
By the Numbers
With over 25 years of experience in the international biotechnology and innovation field, Elena Rivas is among the leading figures in the Spanish life sciences ecosystem. Aiming to transform scientific discoveries into sustainable companies and deliver them to patients, Rivas collaborates with various investment funds to finance startups conducting research in cancer treatment.
Noting that technologies such as precision medicine, artificial intelligence, and liquid biopsy have radically changed the way we understand and treat cancer, Rivas emphasizes that scientific excellence alone is not sufficient. As a founding partner of organizations like Pinnacle Biopartners and Bionido Capital, she helps build next-generation biotechnology companies by bringing private equity together with the scientific community.
Expressing that cancer remains one of the greatest health challenges today but that we are in a unique era for innovation, Rivas states that the main challenge is transforming knowledge into solid companies and attracting the necessary funding. She notes that when science, entrepreneurship, and investment align, innovation will reach patients by creating a tangible impact.
React to this story
Ask about this story
Answers are AI-generated from this story only.
Frequently Asked Questions
- 1. Q: What is Elena Rivas's main goal?
- A: To transform scientific discoveries into sustainable businesses, thereby accelerating the delivery of innovative developments in cancer treatment to patients.
- 2. Q: Which new technologies are prominent in cancer treatment?
- A: Technologies such as precision medicine, advanced therapies, liquid biopsy, artificial intelligence, and computational biology are changing the approach to cancer.
- 3. Q: What is the biggest challenge in the growth of biotechnology startups?
- A: Transforming scientific knowledge into strong companies and attracting sufficient funding to accelerate the integration of these innovations into the healthcare system.
This is an AI-generated summary. The full story lives at the source.
Read the full story at the sourceokdiario.comHow we produce our content →